AB
Arcus Biosciences Inc
🇺🇸XNYS.RCUSUnited StatesHealthcare
$23.88USDdown -0.19 (-0.79%)ClosedEnd of day10:42 PM
Price$23.88-0.19 (-0.79%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- New York Stock Exchange . XNYS
- Type
- Stock
- ISIN
- US03969F1093
- CUSIP
- 03969F109
Company
- Employees
- 601
- Headquarters
- Hayward, United States
- Website
- https://arcusbio.com
- CEO
- Dr. Terry J. Rosen Ph.D.
Market
- Shares outstanding
- 127.3M
- Market cap
- $3.04B
Key dates
- Next earnings
- Oct 27, 2026
Highlights
- Market cap
- $3.04B
- EPS LTM
- -$3.58
- P/E LTM
- -8.60
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $117M-55.34%down year on year
- Net income
- -$452M-47.71%down year on year
- Gross margin
- 94.02%-2.25%down year on year
- Free cash flow
- -$475M-38.89%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.